Long-term results of living donor liver transplantation for glycogen storage disorders in children

Liver Transplantation

Volumn 13, Issue 6, 2007, Pages 848-852

  Iyer, Shridhar G ^a,b   Chen, Chao Long ^a,b   Wang, Chih Chi ^a,b   Wang, Shih Ho ^a,b   Concejero, Allan M ^a,b   Liu, Yueh Wei ^a,b   Yang, Chin Hsiang ^a,b   Yong, Chee Chien ^a,b   Jawan, Bruno ^a,b   Cheng, Yu Fan ^a,b   Eng, Hock Liu ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZATHIOPRINE; CEFTAZIDIME; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; FLUCONAZOLE; GANCICLOVIR; HEPATITIS B VACCINE; LAMIVUDINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROSTAGLANDIN E1;

ACUTE PANCREATITIS; ADOLESCENT; ARTICLE; BALLOON DILATATION; BILE LEAKAGE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 3; GROWTH RETARDATION; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; LACTIC ACIDOSIS; LIVER ADENOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; LIVER WEIGHT; LIVING DONOR; MALE; METABOLIC DISORDER; MORBIDITY; MYCOSIS; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECIPIENT; SEPSIS; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT INDICATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLYCOGEN STORAGE DISEASE TYPE I; GLYCOGEN STORAGE DISEASE TYPE III; GROWTH DISORDERS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 34250678527     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21151     Document Type: Article

References (20)

1. Burchell A. Glycogen storage diseases and the liver. Baillieres Clin Gastroenterol 1998; 12:337-354.
2. Chen, YT. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw-Hill, 2001:1521-1522.
3. Faivre L, Houssin D, Valayer J, Brouard J, Hadchouel M, Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage diseases type 1a. J Inherit Metab Dis 1999;22:723-732.
4. Conti JA, Kemeny N. Type I glycogenosis associated with hepatocellular carcinoma. Cancer 1992;69:1320-1322.
5. Siciliano M, De Candia E, Ballarin S, Vecchio FM, Servidei S, Annese R, et al. Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. J Clin Gastroenterol 2000;31:80-82.
6. Haagsma EB, Smit GP, Niezen-Koning KE, Gouw AS, Meerman L, Slooff MJ. Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology 1997;25:537-540.
7. Chen CL, Concejero A, Wang CC, Wang SH, Lin CC, Liu YW, et al. Living donor liver transplantation for biliary atresia: a single-center experience with first 100 cases. Am J Transplant 2006;6:2672-2679.
8. Lin CC, Chen CL, Concejero A, Wang CC, Wang SH, Liu YW, et al. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant 2007;7:195-200.
9. Smit GP, Berger R, Potasnick R, Moses SW, Fernandes J. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatr Res 1984; 18:879-881.
10. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997;24:276-279.
11. Kirschner BS, Baker AL, Thorp FK. Growth in adulthood after liver transplantation for glycogen storage disease type I. Gastroenterology 1991;101:238-241.
12. Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, et al. Liver transplantation for glycogen storage disease types I, III, and TV. Eur J Pediatr 1999;158(Suppl 2):S43-S48.
13. Liu PP, de Villa VH, Chen YS, Wang CC, Wang SH, Chiang YC, et al. Outcome of living donor liver transplantation for glycogen storage disease. Transplant Proc 2003;35:366-368.
14. Jawan B, Tseng CC, Chen YS, Wang CC, Cheng YF, Huang TL, et al. Is there any difference in anesthetic management of biliary atresia and glycogen storage disease patients undergoing liver transplantation? J Surg Res 2005;126:82-85.
15. Lee PJ, Leonard JV. The hepatic glycogen storage diseases-problems beyond childhood. J Inherit Metab Dis 1995; 18:462-472.
16. Baker L, Dahlem S, Goldfarb S, Kern EF, Stanley CA, Egler J, et al. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 1989;35:1345-1350.
17. Smit GP, Fernandes J, Leonard JV, Matthews EE, Moses SW, Odievre M, et al. The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis 1990; 13:411-418.
18. Michels VV, Beaudet AL. Hemorrhagic pancreatitis in a patient with glycogen storage disease type I. Clin Genet 1980;17:220-222.
19. Kikuchi M, Hasegawa K, Handa I, Watabe M, Narisawa K, Tada K. Chronic pancreatitis in a child with glycogen storage disease type I. Eur J Pediatr 1991;150:852-853.
20. Rowland M, Tozer TN. Clinical Pharmacokinetics-Concepts and Applications. 3rd ed. Philadelphia: Williams and Wilkins, 1995:258.